Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group. Read more about Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
Imaging tumor burden in the brain with 89Zr-transferrin. Read more about Imaging tumor burden in the brain with 89Zr-transferrin.
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial. Read more about Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
Experimental radionuclide therapy of HER2-expressing xenografts using two-step targeting nuclisome particles. Read more about Experimental radionuclide therapy of HER2-expressing xenografts using two-step targeting nuclisome particles.
Novel mechanistic insights into arginine deiminase pharmacology suggest 18F-FDG is not suitable to evaluate clinical response in melanoma. Read more about Novel mechanistic insights into arginine deiminase pharmacology suggest 18F-FDG is not suitable to evaluate clinical response in melanoma.
Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT. Read more about Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT.
CGMP for PET drugs: important steps to take now. Read more about CGMP for PET drugs: important steps to take now.
Design of targeted cardiovascular molecular imaging probes. Read more about Design of targeted cardiovascular molecular imaging probes.
Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment. Read more about Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment.
